NASDAQ:LKFT Lakefront Biotherapeutics American Depositary Shares Q3 2026 Earnings Results & Report $33.34 -0.07 (-0.21%) As of 04:00 PM Eastern Lakefront Biotherapeutics American Depositary Shares reported Q3 2026 earnings on November 11, 2026. The company reported EPS of -$0.05, while revenue was $7.87 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 11, 2026TimeAfter Market ClosesConference Call DateNovember 13, 2026Conference Call7:00 AM ET Lakefront Biotherapeutics American Depositary Shares EPS ResultsActual EPS-$0.05Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate6 of last 8 quartersLakefront Biotherapeutics American Depositary Shares Revenue ResultsActual Revenue$7.87 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress ReleaseEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release Lakefront Biotherapeutics American Depositary Shares Q3 2026 Earnings FAQ Did Lakefront Biotherapeutics American Depositary Shares beat earnings estimates for Q3 2026? Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) reported earnings of -$0.05 per share for Q3 2026. The report was announced on Wednesday, November 11, 2026. What was Lakefront Biotherapeutics American Depositary Shares' revenue for Q3 2026? Lakefront Biotherapeutics American Depositary Shares reported revenue of $7.87 million for Q3 2026. Lakefront Biotherapeutics American Depositary Shares Earnings HeadlinesIs Lakefront Biotherapeutics (ENXTAM:LKFT) Cheap Given Its Earnings Today?1 hour ago | finance.yahoo.comLakefront Biotherapeutics Reports Nine Months 2026 Financial Results and Provides Business UpdateNovember 11 at 4:01 PM | globenewswire.comMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.November 11 at 1:00 AM | Weiss Ratings (Ad)Lakefront to Present at the 2026 Jefferies Global Healthcare Conference in LondonNovember 10 at 4:01 PM | globenewswire.comLakefront Biotherapeutics Announces Poster Presentation at the 2026 American Society of Hematology MeetingNovember 4, 2026 | globenewswire.comReviewing I-Mab (NASDAQ:NBP) & Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT)November 4, 2026 | americanbankingnews.comSee More Lakefront Biotherapeutics American Depositary Shares Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Lakefront Biotherapeutics American Depositary Shares? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lakefront Biotherapeutics American Depositary Shares and other key companies, straight to your email. Email Address About Lakefront Biotherapeutics American Depositary SharesLakefront is a clinical-stage biotechnology company developing therapies in immunology and inflammation. Its clinical-stage portfolio includes lead asset gamgertamig, a BCMAxCD3 T-cell engager being developed for the treatment of autoimmune diseases. The company identifies, acquires, and advances therapeutic assets through business development and clinical development activities. Lakefront evaluates opportunities for portfolio expansion based on their scientific, clinical, and commercial potential. Lakefront focuses on developing medicines for diseases with unmet medical needs and advancing its product candidates through clinical development.View Lakefront Biotherapeutics American Depositary Shares ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Keeping AI Cool: AAON Rides the AI Heatwave to Record GrowthCan Constellation Energy's Contracts Power a Stock Rebound?IonQ Raised the Bar, But 3 Quantum Rivals Face Tough QuestionsAmazon's Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI DemandAST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn't Going AwayPowering Up the Moon: Redwire’s $40 Million NASA Award Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
